81 FR 92858 - Notice of Intent to Grant Partially Exclusive License

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

Federal Register Volume 81, Issue 244 (December 20, 2016)

This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive, license in the United States to practice the inventions described and claimed in U.S. Patent No. 7,623,972 entitled ``Detection of Presence of Chemical Precursors''; U.S. Patent No. 7,801,687 entitled ``Chemical Sensors Using Coated Or Doped Carbon Nanotube Networks''; U.S. Patent No. 7,968,054 entitled ``Nanostructure Sensing and Transmission of Gas Data''; U.S. Patent No. 8,000,903 entitled ``Coated or Doped Carbon Nanotube Network Sensors as Affected by Environmental Parameters''; ARC-16292-1 entitled ``Nanosensor/Cell Phone Hybrid for Detecting Chemicals and Concentrations''; ARC-16902-1, entitled ``Nanosensor for Medical Diagnoses''; ARC-17110-1 entitled ``Detection of Gases and Vapors at Low Concentrations'' to ENDO Medical Inc., having its principal place of business at 2345 Yale Street, 1st Floor, Palo Alto, CA 94306. The patent rights in this invention have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.

[Federal Register Volume 81, Number 244 (Tuesday, December 20, 2016)]
[Notices]
[Page 92858]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-30501]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (16-089)]


Notice of Intent to Grant Partially Exclusive License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of Intent to Grant Partially Exclusive License.

-----------------------------------------------------------------------

SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(e) and 
37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant 
a partially exclusive, license in the United States to practice the 
inventions described and claimed in U.S. Patent No. 7,623,972 entitled 
``Detection of Presence of Chemical Precursors''; U.S. Patent No. 
7,801,687 entitled ``Chemical Sensors Using Coated Or Doped Carbon 
Nanotube Networks''; U.S. Patent No. 7,968,054 entitled ``Nanostructure 
Sensing and Transmission of Gas Data''; U.S. Patent No. 8,000,903 
entitled ``Coated or Doped Carbon Nanotube Network Sensors as Affected 
by Environmental Parameters''; ARC-16292-1 entitled ``Nanosensor/Cell 
Phone Hybrid for Detecting Chemicals and Concentrations''; ARC-16902-1, 
entitled ``Nanosensor for Medical Diagnoses''; ARC-17110-1 entitled 
``Detection of Gases and Vapors at Low Concentrations'' to ENDO Medical 
Inc., having its principal place of business at 2345 Yale Street, 1st 
Floor, Palo Alto, CA 94306. The patent rights in this invention have 
been assigned to the United States of America as represented by the 
Administrator of the National Aeronautics and Space Administration. The 
prospective partially exclusive license will comply with the terms and 
conditions of 35 U.S.C. 209 and 37 CFR 404.7.

DATES: The prospective partially exclusive license may be granted 
unless, within fifteen (15) days from the date of this published 
notice, NASA receives written objections including evidence and 
argument that establish that the grant of the license would not be 
consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. 
Competing applications completed and received by NASA within fifteen 
(15) days of the date of this published notice will also be treated as 
objections to the grant of the contemplated partially exclusive 
license.
    Objections submitted in response to this notice will not be made 
available to the public for inspection and, to the extent permitted by 
law, will not be released under the Freedom of Information Act, 5 
U.S.C. 552.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of Chief Counsel, NASA Ames 
Research Center, Mail Stop 202A-4, Moffett Field, CA 94035-1000. (650) 
604-5104; Fax (650) 604-2767.

FOR FURTHER INFORMATION CONTACT: Robert M. Padilla, Chief Patent 
Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop 
202A-4, Moffett Field, CA 94035-1000. (650) 604-5104; Fax (650) 604-
2767. Information about other NASA inventions available for licensing 
can be found online at http://technology.nasa.gov/.

Mark P. Dvorscak,
Agency Counsel for Intellectual Property.
[FR Doc. 2016-30501 Filed 12-19-16; 8:45 am]
 BILLING CODE 7510-13-P